Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging


The hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
None reported
What to do
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Contact: Plantimex toll-free at 855-752-6869 from 9 a.m. to 4 p.m. PT Monday through Friday, email at customercare@plantimexusa.com with the subject "RECALL" or online at http://plantimexusa.com/contact.php or www.plantimexusa.com and contact us for more information.
Which products are recalled
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
- Recall date
- December 18, 2025
- Recall number
- 26157
- Product
- Mamisan Pain Relieving Topical Ointment
- Units affected
- About 50,330
- Company
- MiramarLab, of Doral, Florida
- Made in
- United States
Sold at: Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
Check if you own it
Compare the product name, model number and date range above with the label on your product (check the back, bottom or packaging). If it matches, stop using it, then use the remedy above. It is free.
Source: U.S. Consumer Product Safety Commission, recall 26157. This page summarizes the public notice; the official notice is authoritative.


